GMA MEDICAL DIRECTOR, RLT

Summary As the Global Medical Director, you will play a critical role in leading the medical strategy for the RLT therapeutic area and acting as the enterprise medical voice across the asset lifecycle.
Your expertise and leadership will contribute to the advancement and success of our RLT programme ensuring the highest quality patient care and outcomes.
This role will work directly with the Global Medical Affairs RLT Team and reports to Head of Global Medical Affairs RLT Oncology.
About the Role Major accountabilities.
Lead the development and execution of medical affairs strategy for Novartis programs, including transformative tactics such as research/population health, innovative partnerships, and integrated evidence plans.
Co-develop plans for evidence generation, MSL/Field Medical Affairs strategy, medical education programs, scientific publication planning, and Medical Expert network development.
Co-own the development and implementation of innovative education and scientific communication plans for external stakeholders.
Plan and monitor the budget to ensure timely and cost-effective development and execution of medical activities.
Prepare submissions for company-sponsored studies and research collaborations.
Partner with cross-functional teams to shape the portfolio early and diversify evidence to achieve broad access at launch and enhance impact on clinical practice.
Represent GMA with internal and external audiences, collaborating with cross-functional partners and industry collaborators/partners.
Represent "the voice of the patient" internally and evaluate factors relevant to a patient's informed decision-making.
Provide direction and input into the development and implementation of successful reimbursement and market access strategies.
Provide proactive input to the development of potential new therapeutic indications and consider new therapeutic opportunities.
Ensure GMA activities are designed and executed in compliance with company policy guidelines and highest medical quality standards.
Requirements.
MD (Preferred) or PhD/PharmD in Health Sciences.
Specialist Degree or specialist qualification related to the discipline is an advantage.
Several years of experience in Medical Affairs and/or Clinical Development within the pharmaceutical industry.
Preferably within Oncology.
Fluent English (Both spoken and written) Critical thinker with the ability to navigate uncertainty without major supervision.
Strategic mindset and ability to establish credibility and influence across diverse stakeholders in a matrix organization.
Proven ability to collaborate across multiple functions and regions/countries.
Deep understanding of healthcare systems and key external stakeholders.
Strong track record of delivery focus for time and quality in medical affairs projects.
Successful development and implementation of innovative programs and processes.
Familiarity with GCP, scientific and clinical methodology, protocol designs, management, and regulatory requirements for clinical studies.
Knowledge of Radiopharmaceuticals would be beneficial Preferred  Highly preferred.
experience particularly with radiopharmaceuticals, nuclear medicine, imaging, significant medical affairs early asset lifecycle, pre-launch and launch experience in Global organizations Oncology experience, ideally Breast Cancer, Lung Cancer, Gastro-intestinal Cancer, Neuroendocrine Cancer; Prostate Cancer Experience in developing and executing “Best in Class” processes at scale Clinical trial research experience conducted in a pharmaceutical or equivalent academic environment in TA of interest is strongly desired